<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02917980</url>
  </required_header>
  <id_info>
    <org_study_id>XJ-20160829</org_study_id>
    <nct_id>NCT02917980</nct_id>
  </id_info>
  <brief_title>Surgery and Transcatheter Intervention for Structural Heart Diseases</brief_title>
  <official_title>Multicenter Registry Study of Surgery and Transcatheter Intervention for Structural Heart Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xijing Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fu Wai Hospital, Beijing, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Anzhen Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wuhan Union Hospital, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Xijing Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project aimed to optimize the therapeutic strategy for structural heart disease by&#xD;
      choosing optimal treatment, such as,surgical treatment,interventional and surgery combined&#xD;
      with interventional hybrid treatment. Thereby improve successful rate of clinical treatment,&#xD;
      and establish the guideline for treatment of structural heart disease.At the same time,online&#xD;
      registration database for structural heart disease will be established to further data&#xD;
      analysis and objective assessment of clinical curative effect for structural heart disease in&#xD;
      China.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This project is a 5 years prospective,observational,longitudinal registration study on&#xD;
      clinical surgical and interventional treatment of structural heart disease.Firstly,patients&#xD;
      with structural heart disease, whom received surgical,interventional or surgery combined with&#xD;
      interventional hybrid treatment during Jan. 2015 to Jan. 2020 ,were registrated dynamiclly.&#xD;
      And further management and 1 year clinical follow-up,which contains demographic&#xD;
      characteristics, clinical manifestations, treatment strategies and prognosis of outcome, were&#xD;
      performed on the recruited data.Secondly, this is also a prospective observational study,&#xD;
      featured by collecting data through annual follow-up,with the timing at the point of off the&#xD;
      hospital,and 1,2,6,9,12 month after hospital discharge,respectively.&#xD;
&#xD;
      The inclusion criteria:&#xD;
&#xD;
        1. atrial septal defect&#xD;
&#xD;
        2. ventricular septal defect&#xD;
&#xD;
        3. patent ductus arteriosis&#xD;
&#xD;
        4. pulmonary stenosis&#xD;
&#xD;
        5. residual leakage after surgical treatment for congenital heart disease&#xD;
&#xD;
        6. coronary artery fistula&#xD;
&#xD;
        7. pulmonary arteriovenous malformations&#xD;
&#xD;
        8. tetralogy of Fallot, and other cyanotic heart disease&#xD;
&#xD;
        9. mitral stenosis and insufficiency&#xD;
&#xD;
       10. tricuspid stenosis and insufficiency&#xD;
&#xD;
       11. aortic stenosis and insufficiency&#xD;
&#xD;
       12. pulmonary stenosis and insufficiency&#xD;
&#xD;
       13. coarctation of aorta&#xD;
&#xD;
       14. paravalvular leakage&#xD;
&#xD;
       15. hypertrophic obstructive heart disease&#xD;
&#xD;
       16. dilated cardiomyopathy&#xD;
&#xD;
       17. structural heart disease need surgery combined with interventional hybrid treatment&#xD;
&#xD;
       18. structural heart disease need surgeryor interventional treatment&#xD;
&#xD;
      The exclusion criteria:&#xD;
&#xD;
        1. primary arrhythmia cardiac disease,like tachycardia and ventricular fibrillation&#xD;
&#xD;
        2. circulation disease, like coronary heart disease,hypertension,arterial aneurysm&#xD;
&#xD;
        3. patients were not received any treatment&#xD;
&#xD;
        4. patients were hard to follow-up&#xD;
&#xD;
        5. no informed Consent&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">January 2020</completion_date>
  <primary_completion_date type="Anticipated">January 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Death from any cause</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Cumulative MACE</measure>
    <time_frame>12 months</time_frame>
    <description>Cumulative MACE (including death, rupture, paraplegia, aneurysm formation et al)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Acute or chronic renal insufficiency</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>residual shunt or regurgitation</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cerebral incidence</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hemolysis</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>Data Collecting and Analyzing of Different Treatment of Structural Heart Diseases</condition>
  <arm_group>
    <arm_group_label>surgical treatment</arm_group_label>
    <description>patients with structural heart disease received surgical treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>interventional treatment</arm_group_label>
    <description>patients with structural heart disease received interventional treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>surgical combined with interventional treatment</arm_group_label>
    <description>patients with structural heart disease received surgical combined with interventional treatment</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with structural heart disease, whom received surgical,interventional or surgery&#xD;
        combined with interventional hybrid treatment&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        1.atrial septal defect 20ventricular septal defect 3.patent ductus arteriosis 4.pulmonary&#xD;
        stenosis 5.residual leakage after surgical treatment for congenital heart disease&#xD;
        6.coronary artery fistula 7.pulmonary arteriovenous malformations 8.tetralogy of Fallot,&#xD;
        and other cyanotic heart disease 9.mitral stenosis and insufficiency 10.tricuspid stenosis&#xD;
        and insufficiency 11.aortic stenosis and insufficiency 12.pulmonary stenosis and&#xD;
        insufficiency 13.coarctation of aorta 14.paravalvular leakage 15.hypertrophic obstructive&#xD;
        heart disease 16.dilated cardiomyopathy 17.structural heart disease need surgery combined&#xD;
        with interventional hybrid treatment 18.structural heart disease need surgeryor&#xD;
        interventional treatment&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. primary arrhythmia cardiac disease,like tachycardia and ventricular fibrillation&#xD;
&#xD;
          2. circulation disease, like coronary heart disease,hypertension,arterial aneurysm&#xD;
&#xD;
          3. patients were not received any treatment&#xD;
&#xD;
          4. patients were hard to follow-up&#xD;
&#xD;
          5. no informed Consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jian Yang, M.D Ph.D</last_name>
    <phone>13892828016</phone>
    <email>yangjian1212@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jiayou Tang, M.D Ph.D</last_name>
    <phone>15353618121</phone>
    <email>dr_shaddock@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Xijing Hospital</name>
      <address>
        <city>Xi'an</city>
        <state>Shaanxi</state>
        <zip>710032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jian Yang, M.D Ph.D</last_name>
      <phone>13892828016</phone>
      <email>yangjian1212@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Jiayou Tang, M.D Ph.D</last_name>
      <phone>15353618121</phone>
      <email>tjy-heart@outlook.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <study_first_submitted>September 27, 2016</study_first_submitted>
  <study_first_submitted_qc>September 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 28, 2016</study_first_posted>
  <last_update_submitted>September 27, 2016</last_update_submitted>
  <last_update_submitted_qc>September 27, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 28, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>structural Heart Diseases</keyword>
  <keyword>surgical treatment</keyword>
  <keyword>interventional treatment</keyword>
  <keyword>hybrid treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

